Recombinant Anti-ERBB3 (Domain 1 x Domain 3) Biparatopic Antibody, Tandem scFv (Clone 1153 x Clone 920104) (CAT#: VS-0525-YC72)

The Recombinant Anti-ERBB3 (Domain 1 x Domain 3) Biparatopic Antibody, Tandem scFv (Clone 1153 x Clone 920104) is a biparatopic antibody (bpAb) crafted to interact with two distinct ERBB3 epitopes. The bpAb's tandem scFv arrangement comprises the 1153 scFv (binding ERBB3 domain 1) N-terminally fused to the 920104 scFv (targeting ERBB3 domain 3). Both domains 1 and 3 are critical for ERBB3 ligand binding. This dual binding offers a more comprehensive blockade of ERBB3 signaling than single monoclonal antibodies.

Specific Inquiry
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location and Protein Expression
Normal Tissue
RNA Expression

Specifications

  • Host Animal 1
  • Mouse
  • Host Animal 2
  • Mouse
  • Specificity
  • Human ERBB3
  • Species Reactivity
  • Human
  • Type
  • Tandem scFv
  • Valency
  • 1 + 1
  • Clone 1
  • 1153
  • Clone 2
  • 920104
  • Epitope 1
  • Domain 1 (for ligand binding)
  • Epitope 2
  • Domain 3 (for ligand binding)
  • Purity
  • >90%
  • Purification
  • Affinity purified
  • Applications
  • ELISA, FC
  • Concentration
  • Lot specific
  • Buffer
  • PBS, pH 7.4
  • Preservative
  • No preservatives
  • Storage
  • Store at 4°C for short term. Aliquot and store at -20°C for long term. Avoid freeze-thaw cycles.
  • Long Name
  • Erb-B2 Receptor Tyrosine Kinase 3

Target

  • Introduction
  • This gene encodes a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. This membrane-bound protein has a neuregulin binding domain but not an active kinase domain. It therefore can bind this ligand but not convey the signal into the cell through protein phosphorylation. However, it does form heterodimers with other EGF receptor family members which do have kinase activity. Heterodimerization leads to the activation of pathways which lead to cell proliferation or differentiation. Amplification of this gene and/or overexpression of its protein have been reported in numerous cancers, including prostate, bladder, and breast tumors. Alternate transcriptional splice variants encoding different isoforms have been characterized. One isoform lacks the intermembrane region and is secreted outside the cell. This form acts to modulate the activity of the membrane-bound form. Additional splice variants have also been reported, but they have not been thoroughly characterized.
  • Alternative Names
  • HER3; FERLK; LCCS2; VSCN1; ErbB-3; c-erbB3; erbB3-S; MDA-BF-1; c-erbB-3; p180-ErbB3; p45-sErbB3; p85-sErbB3

Related Resources

  • Related Diseases
  • Related Signaling Pathways

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "ERBB3"

Select a product category from the dropdown menu below to view related products.
Please select product type
Single Domain Antibody Products Immunotoxin Products Human Antibody Products Mouse Antibody Products Humanized Antibody Products Chimeric Antibody Products Neutralizing Antibody Products Rabbit Monoclonal Antibody Products IgG Antibody Products ScFv Antibody Products ADCC Enhanced Antibody Products Fab Antibody Products Antibody Magnetic Beads ScFv-Fc Chimera Products Extracellular Vesicle (EV) Antibody Products IHC Kit and Antibody Products: Precision Tools for Immunohistochemistry Biparatopic Antibody (bpAb) Products

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for VS-0525-YC72. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare